Many preschool children develop recurrent respiratory tract infections (RRI). Strategies to prevent RRI include the use of immunomodulators as pidotimod or probiotics, but there is limited evidence of their efficacy on clinical features or on urine metabolic profile.
Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial / Santamaria, F.; Montella, S.; Stocchero, M.; Pirillo, P.; Bozzetto, S.; Giordano, G.; Poeta, M.; Baraldi, E.. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - 58:11(2019), p. 101818. [10.1016/j.pupt.2019.101818]
Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial
Santamaria F.
Conceptualization
;Montella S.Membro del Collaboration Group
;Poeta M.Membro del Collaboration Group
;
2019
Abstract
Many preschool children develop recurrent respiratory tract infections (RRI). Strategies to prevent RRI include the use of immunomodulators as pidotimod or probiotics, but there is limited evidence of their efficacy on clinical features or on urine metabolic profile.| File | Dimensione | Formato | |
|---|---|---|---|
|
santamaria Pulm Pharmacol Ther. 2019.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
766.16 kB
Formato
Adobe PDF
|
766.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
